Antidepressant Drug Vilazodone Hydrochloride CAS 163521-12-8

Basic Info

Model No.:  163521-12-8

Additional Info

Packaging: As required

Productivity: Commercial

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Certificate: Technical Support

Product Description

Vilazodone hydrochloride CAS number is 163521-12-8, which is the first steroidal amine to treat major depression in adults, which has a dual role and is a selective serotonin reuptake inhibitor and 5-HT1A receptor Partial agonists. In January 2011, the US Food and Drug Administration (FDA) approved the use of vilazodone hydrochloride tablets for the treatment of adults with major depressive disorder (MDD). vilazodone hydrochloride is a novel antidepressant drug that binds with high affinity to the serotonin reuptake site but does not have high affinity for norepinephrine or dopamine reuptake sites. It selectively inhibits serotonin reuptake. It also binds to the 5-HT1A receptor with high affinity and is a partial agonist of the 5-HT1A receptor. Product Advantages Clinical data tests showed that Vilazodone hydrochloride CAS number 163521-12-8 has a fast onset, does not increase body weight, and does not affect sexual function. Its efficacy is significantly better than placebo, with good tolerance and low side effects. Common adverse reactions are diarrhea, nausea, vomiting and insomnia. These adverse reactions occur early in the treatment and do not result in the termination of treatment with Vilazodone hydrochloride. The market predicts that annual sales of Vilazodone hydrochloride is expected to exceed $1 billion. The launch of new products in seven global markets will enable the rapid expansion of the depression drug market, which is expected to grow from $11.9 billion in 2010 to $14 billion in 2020, with a compound annual growth rate of 2.5%, making depression drugs The market has become the largest branch of the central nervous system disease. The current research on new drugs for depression will compete as a second- and third-line treatment drug for the market share of depression drugs. According to the relevant treatment guidelines, the prescription drug for depression is usually the first choice for a generic ssris drug, and then with a drug such as agomelatine, vilazodone etc. as the initial treatment, so the market prospects is very worth looking forward to.

Thera. Category:Anti-depressed

Cas No.:163521-12-8

Synonyms:Vilazodone, >=98%;Vilozodone;VILAZODONE; 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide;2-BenzofurancarboxaMide,5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-;Vilazodonei;Vilazodone 5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide;5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide;

NW: 477.993

M.W.: C26H27N5O2.ClH

Assay: ≥99%

Packing:Export worthy packing

Material Safety Data Sheet:Available on request